Category: Pharmacology

Your drug info question is below. Keep in mind, oftentimes I will include a bunch of smaller questions that should help answer the bigger question, but there may be other things that you find that I do not include:

Also, I’d recommend referring to UpToDate, EULAR Rheumatoid Arthritis guidelines, and ACR Rheumatoid Arthritis Guidelines for generally knowing RA treatment. (UpToDate is the easiest if you have access). For the above, I DO want you to look at any current meta-analyses or systematic reviews to help craft your answer. I do not want you to refer to randomized control trials or observational trials UNLESS they are answering something that the meta-analyses or systematic reviews are not addressing.

Part 1: In rheumatoid arthritis (RA) after the failure of nonbiologic DMARDs, we typically use the following drug classes next: TNFa inhibitors, JAK inhibitors, IL6, IL1R, antiCD20, and immunosuppressants (specifically abatacept). Current guidelines allow the use of any of these after the failure of nonbiologic DMARDs, but they do not directly state which of these therapies to use first. So, the question is what does the current evidence say as to which drug therapies outperform all others?
So, what review articles are out there that compares all non-biologic DMARDs to each other?
How are these review articles deciding which is best?
Which specific medications of the above drug classes tend to be the most recommended based on the data from these review articles
Just to help you out, here are some articles I found. Feel free to use these, BUT there may be other similar articles out there. I used the key words “rheumatoid arthritis biologic therapies comparison” BUT you may want to explore other phrases. I also select the ‘review’ article option in most search engines. I use either Google scholar or PubMed.
Network meta‐analysis of tofacitinib versus biologic treatments in moderate‐to‐severe rheumatoid arthritis patients – Camean‐Castillo – 2019 – Journal of Clinical Pharmacy and Therapeutics – Wiley Online Library
https://www.cureus.com/articles/93507-tumor-necrosis-factor-alpha-inhibitors-and-cardiovascular-risk-in-rheumatoid-arthritis-a-systematic-review.pdf
You can also utilize references included from UpToDate
Part 2: Of the class of TNFa inhibitors, there are both infusion and self-injectable therapies. Recall infusions are therapies where the patient actually has to sit for 30 min or more with an IV and receive the therapy over time – obviously this is more inconvenient, but they are typically being monitored by a healthcare provider to either adjust dose or monitor for any effects. Self-injectable therapies require no healthcare provider – the patient just gets the injectable and they can inject themselves at the convenience of their own home. So:
What does the literature say regarding whether an infused therapy vs self-injectable TNFalpha inhibitors is preferred in RA patients? (You do NOT need to focus on randomized controlled trials or observational trials, it should be mainly from meta-analyses or systematic reviews)
Again, some example articles I found. I used keywords: “infusion vs self-injectable tnf inhibitors administration rheumatoid arthritis.”
Trends in the Use of Biologic Agents Among Rheumatoid Arthritis Patients Enrolled in the US Medicare Program – Zhang – 2013 – Arthritis Care & Research – Wiley Online Library
Rheumatoid Arthritis: An Updated Overview of Latest Therapy and Drug Delivery – PMC (nih.gov)
You’ll notice there are studies outside of our population (For example, Medicare vs commercial; however, I do not care as much about this only because there’s a low volume of studies out there anyway)

Read a selection of your colleagues’ responses and respond to at least two of your colleagues on two different days who selected a different type of diabetes than you did. Provide recommendations for alternative drug treatments and patient education strategies for treatment and management.
colleaque post 1
Explanation of the Differences Between the Types of Diabetes
Diabetes is a chronic disease that affects how the body processes blood sugar (glucose). There are several types of diabetes, including type 1, type 2, gestational, and juvenile diabetes (Khan et al., 2019). Type 1 diabetes is an autoimmune disease that usually develops in childhood or adolescence (Akil et al., 2021). It occurs when the immune system attacks and destroys the beta cells in the pancreas, which are responsible for producing insulin (Akil et al., 2021). People with type 1 diabetes need to take insulin injections or use an insulin pump to manage their blood sugar levels (Akil et al., 2021). Type 2 diabetes is the most common type of diabetes and usually develops in adults. It occurs when the body becomes resistant to insulin or doesn’t produce enough insulin to regulate blood sugar levels (Reed et al., 2021). Type 2 diabetes can be managed with oral medications, insulin, or a combination of both (Reed et al., 2021). Gestational diabetes occurs during pregnancy and usually goes away after the baby is born (Khan et al., 2019). It can increase the risk of complications during pregnancy and delivery, as well as the risk of developing type 2 diabetes later in life (Khan et al., 2019). Juvenile diabetes, also known as type 1 diabetes, is a term used to describe type 1 diabetes that develops in children (Khan et al., 2019).
Drugs Used to Treat Diabetes
One type of drug used to treat type 2 diabetes is metformin (Reed et al., 2021). It works by lowering the amount of glucose the liver produces and increasing the body’s sensitivity to insulin (Reed et al., 2021). Metformin is usually taken orally, with or after meals (Reed et al., 2021). The dosage and frequency of the medication will depend on the individual’s blood sugar levels and other factors (Reed et al., 2021). Dietary considerations related to the treatment of diabetes include monitoring carbohydrate intake and avoiding foods that can cause blood sugar spikes (Magkos et al., 2020). Patients with diabetes may need to follow a specific meal plan or consult with a registered dietitian to help manage their blood sugar levels (Magkos et al., 2020).
Short-Term and Long-Term Impacts
The short-term impact of diabetes on patients can include symptoms such as increased thirst, frequent urination, and fatigue (Reed et al., 2021). In the long run, diabetes can lead to complications such as nerve damage, kidney damage, and cardiovascular disease (Reed et al., 2021). Proper management of blood sugar levels through medication, diet, and exercise can help prevent or delay these complications. However, if left untreated, diabetes can have a significant impact on a patient’s quality of life and overall health (Reed et al., 2021).
Summary
Diabetes is a chronic disease affecting blood sugar processing (Khan et al., 2019). It has several types, including type 1, type 2, gestational, and juvenile diabetes (Khan et al., 2019). Type 1 diabetes is autoimmune and requires insulin injections (Akil et al., 2021). Type 2 diabetes is common and can be managed with oral medications or insulin (Reed et al., 2021). Gestational diabetes occurs during pregnancy and can increase complications (Khan et al., 2019). Metformin is a drug used to treat type 2 diabetes (Reed et al., 2021).
colleaque post 2
Types of Diabetes
There are four types of Diabetes Mellitus (DM): type 1 DM, type 2 DM, juvenile DM, and gestational DM. Type 1 DM was previously known as juvenile DM. It is a chronic condition that occurs when the pancreas makes little or no insulin due to beta cell destruction (Mayo Clinic, 2022). Because of this destruction of beta cells, patients with type 1 DM require lifelong insulin therapy. This type of diabetes typically is diagnosed in childhood or adolescence years with an abrupt onset.
Type 2 diabetes is a more chronic type of DM that exists when adipose and muscle cells begin to resist insulin. This causes the pancreas to create more insulin in an attempt to offset the resistance which progressively leads to hyperglycemia due to the pancreas’s inability to keep up with the demand of insulin (Centers for Disease Control and Prevention, 2022). Lifestyle modifications, oral medications, and noninsulin injectables are all treatments for type 2 DM.
Gestational diabetes presents during pregnancy, typically around 24 to 28 weeks gestation. It occurs because of the influx of hormones and glucocorticoids that are released from the placenta during pregnancy. Gestational diabetes resolves after pregnancy, but it increases the risk of developing type 2 diabetes.
Type 1 Diabetes
Dietary modifications and insulin therapy are two treatment options for type 1 DM. Patients must be educated on the proper use of insulin and dosing in order to prevent hypoglycemic or hyperglycemic episodes. Individuals with type 1 diabetes can be prescribed both a long-acting and short-acting insulin. Levemir is an example of a long-acting insulin. It has a 24-hour duration of action with no pronounced peak and an onset of one to two hours (National Library of Medicine, 2022). It is injected subcutaneously into the fatty tissue that can be found in the abdomen, upper arms, or thighs. For once daily doses, Levemir should be administered with evening meal or at bedtime (Medscape, 2023). It is important to educate patients to check their blood glucose prior to taking insulin to prevent hypoglycemia. For those that take it twice daily, it should be injected with the evening meal, at bedtime, or 12 hours after the morning dose. If injecting in the abdomen, patients should be instructed to inject two inches away from the belly button. Additionally, it is important to educate patients to rotate injection sites to prevent lipodystrophy (National Library of Medicine, 2022). Patients should consume meals on a regular schedule and eat adequate portions to prevent hypoglycemia. Unopened Levemir should be refrigerated or stored at room temperature if it is going to be used within 42 days. An opened Levemir injection pen should be stored at room temperature and used within 42 days (Sinha, 2023).
Hypoglycemia, hyperglycemia, and diabetic ketoacidosis (DKA) are short-term complications of type 1 diabetes. Hypoglycemia can occur from overdosing on diabetic drugs and low dietary intake. Hyperglycemia can result from poor dietary choices, lack of exercise, and undermedication. DKA is a short-term complication that results from having blood sugar for an extensive amount of time. It is life-threatening and occurs when the body starts breaking down fat at a rapid rate and the liver processes the fat into ketones, causing the blood to become acidic (National Library of Medicine, 2023). Long-term complications of type 1 DM are cardiovascular and blood vessel disease, neuropathy, nephropathy, eye damage, foot damage, and pregnancy complications (Mayo Clinic, 2023). Due to these short-term and long-term complications, patients must be adequately instructed and educated regarding their glycemic control, treatments, and lifestyle modifications.
NB
Each response must have at least 2 intext citations in apa
references must be less than 5 years
each response must have a separate reference page
RESPONSE SHOULD POSITIVELY SUPPORT COLLEAQUE AND MUST ADD NEW IDEAS

Your drug info question is below. Keep in mind, oftentimes I will include a bunch of smaller questions that should help answer the bigger question, but there may be other things that you find that I do not include:

Also, I’d recommend referring to UpToDate, EULAR Rheumatoid Arthritis guidelines, and ACR Rheumatoid Arthritis Guidelines for generally knowing RA treatment. (UpToDate is the easiest if you have access). For the above, I DO want you to look at any current meta-analyses or systematic reviews to help craft your answer. I do not want you to refer to randomized control trials or observational trials UNLESS they are answering something that the meta-analyses or systematic reviews are not addressing.

Part 1: In rheumatoid arthritis (RA) after the failure of nonbiologic DMARDs, we typically use the following drug classes next: TNFa inhibitors, JAK inhibitors, IL6, IL1R, antiCD20, and immunosuppressants (specifically abatacept). Current guidelines allow the use of any of these after the failure of nonbiologic DMARDs, but they do not directly state which of these therapies to use first. So, the question is what does the current evidence say as to which drug therapies outperform all others?
So, what review articles are out there that compares all non-biologic DMARDs to each other?
How are these review articles deciding which is best?
Which specific medications of the above drug classes tend to be the most recommended based on the data from these review articles
Just to help you out, here are some articles I found. Feel free to use these, BUT there may be other similar articles out there. I used the key words “rheumatoid arthritis biologic therapies comparison” BUT you may want to explore other phrases. I also select the ‘review’ article option in most search engines. I use either Google scholar or PubMed.
Network meta‐analysis of tofacitinib versus biologic treatments in moderate‐to‐severe rheumatoid arthritis patients – Camean‐Castillo – 2019 – Journal of Clinical Pharmacy and Therapeutics – Wiley Online Library
https://www.cureus.com/articles/93507-tumor-necrosis-factor-alpha-inhibitors-and-cardiovascular-risk-in-rheumatoid-arthritis-a-systematic-review.pdf
You can also utilize references included from UpToDate
Part 2: Of the class of TNFa inhibitors, there are both infusion and self-injectable therapies. Recall infusions are therapies where the patient actually has to sit for 30 min or more with an IV and receive the therapy over time – obviously this is more inconvenient, but they are typically being monitored by a healthcare provider to either adjust dose or monitor for any effects. Self-injectable therapies require no healthcare provider – the patient just gets the injectable and they can inject themselves at the convenience of their own home. So:
What does the literature say regarding whether an infused therapy vs self-injectable TNFalpha inhibitors is preferred in RA patients? (You do NOT need to focus on randomized controlled trials or observational trials, it should be mainly from meta-analyses or systematic reviews)
Again, some example articles I found. I used keywords: “infusion vs self-injectable tnf inhibitors administration rheumatoid arthritis.”
Trends in the Use of Biologic Agents Among Rheumatoid Arthritis Patients Enrolled in the US Medicare Program – Zhang – 2013 – Arthritis Care & Research – Wiley Online Library
Rheumatoid Arthritis: An Updated Overview of Latest Therapy and Drug Delivery – PMC (nih.gov)
You’ll notice there are studies outside of our population (For example, Medicare vs commercial; however, I do not care as much about this only because there’s a low volume of studies out there anyway)

Follow these guidelines when completing each component of the assignment. Contact your course faculty if you have questions.
Complete the outline template. (i uploaded it in the attachement). Links to an external site. provided for the sections highlighted in yellow and the “click to enter text here” is indicated.
Provide references for your protocol at the bottom of the form where indicated. References should come from the following sources:
Clinical Practice Guidelines
DyslipidemiaLinks to an external site. (https://www.ahajournals.org/doi/10.1161/CIR.0000000000000625)
HTNLinks to an external site.
Course Textbook
(https://ambassadored.vitalsource.com/reader/books/9780323554954/epubcfi/6/24[%3Bvnd.vst.idref%3Did_chp00002]!/4/2/4/2[CN]/3:0[%2C2])

I will upload the instructions and an EXAMPLE of how I want the essay to be please use the EXAMPLE one.
AND use AMA citation style.
thank you

PHARMACOTHERAPY FOR GASTROINTESTINAL AND HEPATOBILIARY DISORDERS
Gastrointestinal (GI) and hepatobiliary disorders affect the structure and function of the GI tract. Many of these disorders often have similar symptoms, such as abdominal pain, cramping, constipation, nausea, bloating, and fatigue. Since multiple disorders can be tied to the same symptoms, it is important for advanced practice nurses to carefully evaluate patients and prescribe a treatment that targets the cause rather than the symptom.
Once the underlying cause is identified, an appropriate drug therapy plan can be recommended based on medical history and individual patient factors. In this Assignment, you examine a case study of a patient who presents with symptoms of a possible GI/hepatobiliary disorder, and you design an appropriate drug therapy plan.
RESOURCES
Be sure to review the Learning Resources before completing this activity.
Click the weekly resources link to access the resources.
WEEKLY RESOURCES
To Prepare:
Review the case study assigned by your Instructor for this Assignment
Reflect on the patient’s symptoms, medical history, and drugs currently prescribed.
Think about a possible diagnosis for the patient. Consider whether the patient has a disorder related to the gastrointestinal and hepatobiliary system or whether the symptoms are the result of a disorder from another system or other factors, such as pregnancy, drugs, or a psychological disorder.
Consider an appropriate drug therapy plan based on the patient’s history, diagnosis, and drugs currently prescribed.
BY DAY 7 OF WEEK 4
Write a 1-page paper that addresses the following:
Explain your diagnosis for the patient, including your rationale for the diagnosis.
Describe an appropriate drug therapy plan based on the patient’s history, diagnosis, and drugs currently prescribed.
Justify why you would recommend this drug therapy plan for this patient. Be specific and provide examples.
Reminder: The College of Nursing requires that all papers submitted include a title page, introduction, summary, and references. The Sample Paper provided at the Walden Writing Center offers an example of those required elements (available at http://writingcenter.waldenu.edu/57.htm Links to an external site.). All papers submitted must use this formatting.
SUBMISSION INFORMATION
Before submitting your final assignment, you can check your draft for authenticity. To check your draft, access the Turnitin Drafts from the Start Here area.
To submit your completed assignment, save your Assignment as WK4Assgn_LastName_Firstinitial
Then, click on Start Assignment near the top of the page.
Next, click on Upload File and select Submit Assignment for review.

Rubric
NURS_6521_Week4_Assignment_Rubric
NURS_6521_Week4_Assignment_Rubric
Criteria Ratings Pts
This criterion is linked to a Learning Outcome Explain your diagnosis for the patient, including your rationale for the diagnosis.
25 to >22.25 pts
Excellent
The response accurately and clearly explains in detail the diagnosis for the patient, including an accurate and thorough rationale for the diagnosis that supports clinical judgment.
22.25 to >19.75 pts
Good
The response provides a basic explanation of 1-2 diagnoses for the patient, including an accurate rationale for the diagnosis that may support clinical judgment.
19.75 to >17.25 pts
Fair
The response inaccurately or vaguely explains the diagnosis for the patient, including an inaccurate or vague rationale for the diagnosis that may or may not support clinical judgment.
17.25 to >0 pts
Poor
The response inaccurately and vaguely explains the diagnosis for the patient, including an inaccurate and vague rationale for the diagnosis that does not support clinical judgment, or is missing.
25 pts
This criterion is linked to a Learning Outcome Describe an appropriate drug therapy plan based on the patient’s history, diagnosis, and drugs currently prescribed.
30 to >26.7 pts
Excellent
The response accurately and completely describes in detail an appropriate drug therapy plan based on the patient’s history, diagnosis, and drugs currently prescribed.
26.7 to >23.7 pts
Good
The response describes a basic explanation of the appropriate drug therapy plan based on the patient’s history, diagnosis, and drugs currently prescribed.
23.7 to >20.7 pts
Fair
The response inaccurately or vaguely describes an appropriate drug therapy plan based on the patient’s history, diagnosis, and drugs currently prescribed.
20.7 to >0 pts
Poor
The response inaccurately and vaguely describes an appropriate drug therapy plan based on the patient’s history, diagnosis, and drugs currently prescribed.
30 pts
This criterion is linked to a Learning Outcome Justify why you would recommend this drug therapy plan for this patient. Be specific and provide examples.
30 to >26.7 pts
Excellent
The response provides an accurate, clear, and detailed justification for the recommended drug therapy plan for this patient. … The response includes specific, accurate, and detailed examples that fully support the justification provided.
26.7 to >23.7 pts
Good
The response provides a basic justification for the recommended drug therapy plan for this patient. … The response includes only 1-2 examples that fully support the justification provided.
23.7 to >20.7 pts
Fair
The response provides an inaccurate or vague justification for the recommended drug therapy plan for this patient. … The response may include examples, which may inaccurately or vaguely support the justification provided.
20.7 to >0 pts
Poor
The response provides an inaccurate and vague justification for the recommended drug therapy plan for this patient, or is missing. … The response does not include examples that support the justification provided, or is missing.
30 pts
This criterion is linked to a Learning Outcome Written Expression and Formatting – Paragraph Development and Organization: Paragraphs make clear points that support well developed ideas, flow logically, and demonstrate continuity of ideas. Sentences are carefully focused–neither long and rambling nor short and lacking substance.
5 to >4.45 pts
Excellent
Paragraphs and sentences follow writing standards for flow, continuity, and clarity.
4.45 to >3.95 pts
Good
Paragraphs and sentences follow writing standards for flow, continuity, and clarity 80% of the time.
3.95 to >3.45 pts
Fair
Paragraphs and sentences follow writing standards for flow, continuity, and clarity 60%–79% of the time.
3.45 to >0 pts
Poor
Paragraphs and sentences follow writing standards for flow, continuity, and clarity less than 60% of the time.
5 pts
This criterion is linked to a Learning Outcome Written Expression and Formatting – English writing standards: Correct grammar, mechanics, and proper punctuation
5 to >4.45 pts
Excellent
Uses correct grammar, spelling, and punctuation with no errors
4.45 to >3.95 pts
Good
Contains a few (1–2) grammar, spelling, and punctuation errors
3.95 to >3.45 pts
Fair
Contains several (3–4) grammar, spelling, and punctuation errors
3.45 to >0 pts
Poor
Contains many (≥ 5) grammar, spelling, and punctuation errors that interfere with the reader’s understanding
5 pts
This criterion is linked to a Learning Outcome Written Expression and Formatting – The paper follows correct APA format for title page, headings, font, spacing, margins, indentations, page numbers, running head, parenthetical/in-text citations, and reference list.
5 to >4.45 pts
Excellent
Uses correct APA format with no errors
4.45 to >3.95 pts
Good
Contains a few (1–2) APA format errors
3.95 to >3.45 pts
Fair
Contains several (3–4) APA format errors
3.45 to >0 pts
Poor
Contains many (≥ 5) APA format errors
5 pts
resources
Rosenthal, L. D., & Burchum, J. R. (2021). Lehne’s pharmacotherapeutics for advanced practice nurses and physician assistants (2nd ed.) St. Louis, MO: Elsevier.
Chapter 64, “Drugs for Peptic Ulcer Disease” (pp. 589–597)
Chapter 65, “Laxatives” (pp. 598–604)
Chapter 66, “Other Gastrointestinal Drugs” (pp. 605–616)
Chapter 80, “Antiviral Agents I: Drugs for Non-HIV Viral Infections” (pp. 723–743)
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., . . . Sanya, A. J. (2018). The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases Links to an external site.. Hepatology, 67(1), 328–357. Retrieved from https://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.29367
This article details the diagnosis and management of nonalcoholic fatty liver disease. Review this article to gain an understanding of the underlying pathophysiology as well as the suggested pharmacotherapeutics that might be recommended to treat this disorder.

Doxy-Pep is an option to reduce
the risk of syphilis, gonorrhea and chlamydia for transwomen as well as
gay, bisexual or other men who have sex with men and who have had at
least one of these STIs in the past 12 month.
I am working on a poster project and need n abstract for now.
I need to include at least 10 paper studies within the past 5-10 years.
I will provide an example

Part 1: 5 Pages
The attached file contain several warning letter excerpts. For the purposes of this assignment, we’ll say that these citations comprise one warning letter to an investigator. Your assignment is to draft a response letter from the perspective of the investigator. Provide a response to each of the citations; in your response be sure to describe both how you will fix the issue (corrective action) and put measures in place to prevent it in the future (preventive action). The response should be in letter format with an introduction and conclusion.
Part 2: 5 Pages
Select a warning letter from the FDA database that is, in part, relative to the concepts we’ve covered in this class. Your assignment is to draft a response to that warning letter from the perspective of the investigator. Provide a response to each of the citations; in your response be sure to describe both how you will address the issue (corrective action) and put measures in place to prevent it in the future (preventative action). FDA Warning Letter database: http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/

Read a selection of your colleagues’ responses and respond to at least two of your colleagues on two different days by suggesting additional patient factors that might have interfered with the pharmacokinetic and pharmacodynamic processes of the patients they described. In addition, suggest how the personalized plan of care might change if the age of the patient were different and/or if the patient had a comorbid condition, such as renal failure, heart failure, or liver failure.
colleaque post
Personalized Care for a Geriatric Patient with Hypertension and Polypharmacy
Patient Case:
In my clinical practice over the last 5 years, I encountered a 75-year-old male patient presenting with hypertension and multiple comorbidities, including type 2 diabetes and mild renal impairment. The patient had a history of polypharmacy, taking an array of medications, including antihypertensives, oral hypoglycemic agents, and pain management drugs for osteoarthritis. The complexity of this case highlighted the intricate interplay between pharmacokinetic and pharmacodynamic processes in geriatric patients with multiple health issues.
Influencing Factors on Pharmacokinetics and Pharmacodynamics:
Several factors influenced the pharmacokinetic and pharmacodynamic processes in this patient. Firstly, age-related physiological changes, such as decreased renal function and altered hepatic metabolism, significantly impacted drug clearance rates. The patient’s mild renal impairment reduced the elimination of renally cleared drugs, leading to potential accumulation and increased risk of adverse effects. Furthermore, polypharmacy introduced the risk of drug-drug interactions, which could alter drug metabolism and efficacy (Cho et al., 2022). The patient’s diabetes also affected drug absorption and distribution due to changes in blood flow and protein binding.
Personalized Plan of Care:
The personalized plan of care for this patient involved a comprehensive approach considering the influencing factors and patient history. Firstly, a thorough medication review was conducted to identify potential interactions and redundancies. Reducing polypharmacy by discontinuing non-essential medications helped mitigate the risk of adverse events and improve medication adherence. For instance, the patient was shifted from multiple pain management drugs to a single agent with a lower potential for interactions, enhancing overall safety.
To address altered drug metabolism and elimination due to age-related changes, dosage adjustments were implemented. Medication dosages were adapted based on renal function and hepatic capacity to prevent accumulation and toxicity. For the antihypertensive medication, which was primarily renally eliminated, the dosage was lowered to accommodate the patient’s decreased renal function.
Given the patient’s diabetes, medications with minimal impact on blood glucose levels were prioritized to prevent worsening glycemic control. Additionally, close monitoring of blood pressure and blood glucose levels was established, with a focus on regular follow-up appointments to assess treatment effectiveness and detect any adverse effects promptly.
Patient education played a crucial role in this personalized plan of care. The patient was educated about the importance of medication adherence, potential side effects, and the rationale behind dosage adjustments (Delara et al., 2022). Lifestyle modifications including dietary changes and increased physical activity were also emphasized to complement pharmacological interventions and promote overall health.
In conclusion, the case of the geriatric patient with hypertension and polypharmacy highlighted the intricate relationship between pharmacokinetics, pharmacodynamics, and individual patient factors. The personalized plan of care involved reducing polypharmacy, adjusting dosages based on renal function, selecting medications with minimal interactions, and focusing on patient education. This approach aimed to optimize treatment outcomes, minimize adverse effects, and enhance the patient’s quality of life by tailoring medical interventions to the unique needs of the individual.
Initial question
ost a descriiption of the patient case from your experiences, observations, and/or clinical practice from the last 5 years. Then, describe factors that might have influenced pharmacokinetic and pharmacodynamic processes of the patient you identified. Finally, explain details of the personalized plan of care that you would develop based on influencing factors and patient history in your case. Be specific and provide examples.
NOTE
YOU ARE JUST RESPONDING TO THE POST

ASTHMA AND STEPWISE MANAGEMENT
Asthma is a respiratory disorder that affects children and adults. Advanced practice nurses often provide treatment to patients with these disorders. Sometimes patients require immediate treatment, making it essential that you recognize and distinguish minor asthma symptoms from serious, life-threatening ones. Since symptoms and attacks are often induced by a trigger, advanced practice nurses must also help patients identify their triggers and recommend appropriate management options. Like many other disorders, there are various approaches to treating and managing care for asthmatic patients depending on individual patient factors.
One method that supports the clinical decision making of drug therapy plans for asthmatic patients is the stepwise approach, which you explore in this Assignment.
RESOURCES
Be sure to review the Learning Resources before completing this activity.
Click the weekly resources link to access the resources.
WEEKLY RESOURCES
To Prepare:
Reflect on drugs used to treat asthmatic patients, including long-term control and quick relief treatment options for patients. Think about the impact these drugs might have on patients, including adults and children.
Consider how you might apply the stepwise approach to address the health needs of a patient in your practice.
Reflect on how stepwise management assists health care providers and patients in gaining and maintaining control of the disease.
BY DAY 7 OF WEEK 3
Create a 5- to 6-slide PowerPoint presentation that can be used in a staff development meeting on presenting different approaches for implementing the stepwise approach for asthma treatment. Be sure to address the following:
Describe long-term control and quick relief treatment options for the asthma patient from your practice as well as the impact these drugs might have on your patient.
Explain the stepwise approach to asthma treatment and management for your patient.
Explain how stepwise management assists health care providers and patients in gaining and maintaining control of the disease. Be specific.
SUBMISSION INFORMATION
Before submitting your final assignment, you can check your draft for authenticity. To check your draft, access the Turnitin Drafts from the Start Here area.
To submit your completed assignment, save your Assignment as WK3Assgn_LastName_Firstinitial
Then, click on Start Assignment near the top of the page.
Next, click on Upload File and select Submit Assignment for review.

Rubric
NURS_6521_Week3_Assignment_Rubric
NURS_6521_Week3_Assignment_Rubric
Criteria Ratings Pts
This criterion is linked to a Learning Outcome Describe the long-term control and quick relief treatment options for the asthma patient from your practice, as well as the impact these drugs might have on your patient.
30 to >26.7 pts
Excellent
The presentation clearly and accurately describes in detail the long-term control and quick relief treatment options for the asthma patient from their practice. … The presentation clearly and accurately describes in detail the impact these drugs might have on their patient.
26.7 to >23.7 pts
Good
The presentation accurately describes the long-term control and quick relief options for the asthma patient from their practice. … The presentation accurately describes the impact these drugs might have on their patient.
23.7 to >20.7 pts
Fair
The presentation inaccurately or vaguely describes the long-term control and quick relief options for the asthma patient from their practice. … The presentation inaccurately or vaguely describes the impact these drugs might have on their patient.
20.7 to >0 pts
Poor
The presentation inaccurately and vaguely describes the long-term and quick relief options for the asthma patient from their practice, or is missing. … The presentation inaccurately and vaguely describes the impact these drugs might have on their patient, or is missing.
30 pts
This criterion is linked to a Learning Outcome Explain the stepwise approach to asthma treatment and management for your patient.
30 to >26.7 pts
Excellent
The presentation clearly and accurately explains in detail the stepwise approach to asthma treatment and management for their patient.
26.7 to >23.7 pts
Good
The presentation accurately explains the stepwise approach to asthma treatment and management for their patient.
23.7 to >20.7 pts
Fair
The presentation inaccurately or vaguely explains the stepwise approach to asthma treatment and management for their patient.
20.7 to >0 pts
Poor
The presentation inaccurately and vaguely explains the stepwise approach to asthma treatment and management for their patient.
30 pts
This criterion is linked to a Learning Outcome Explain how stepwise management assists health care providers and patients in gaining and maintaining control of the disease. Be specific.
30 to >26.7 pts
Excellent
The presentation clearly and accurately explains in detail how stepwise management assists health care providers and patients in gaining and maintaining control of the disease. … The presentation provides accurate and detailed examples to support the explanation provided.
26.7 to >23.7 pts
Good
The presentation accurately explains how stepwise management assists health care providers and patients in gaining and maintaining control of the disease. … The presentation provides accurate examples to support the explanation provided.
23.7 to >20.7 pts
Fair
The presentation inaccurately or vaguely explains how stepwise management assists health care providers and patients in gaining and maintaining control of the disease. … The presentation provides inaccurate or vague examples to support the explanation provided.
20.7 to >0 pts
Poor
The presentation inaccurately and vaguely explains how stepwise management assists health care providers and patients in gaining and maintaining control of the disease, or is missing. … The presentation provides inaccurate and vague examples to support the explanation provided, or is missing.
30 pts
This criterion is linked to a Learning Outcome Written Expression and Formatting – Paragraph Development and Organization: Paragraphs make clear points that support well developed ideas, flow logically, and demonstrate continuity of ideas. Sentences are carefully focused–neither long and rambling nor short and lacking substance.
5 to >4.45 pts
Excellent
Paragraphs and sentences follow writing standards for flow, continuity, and clarity.
4.45 to >3.95 pts
Good
Paragraphs and sentences follow writing standards for flow, continuity, and clarity 80% of the time.
3.95 to >3.45 pts
Fair
Paragraphs and sentences follow writing standards for flow, continuity, and clarity 60%–79% of the time.
3.45 to >0 pts
Poor
Paragraphs and sentences follow writing standards for flow, continuity, and clarity less than 60% of the time.
5 pts
This criterion is linked to a Learning Outcome Written Expression and Formatting – English writing standards: Correct grammar, mechanics, and proper punctuation
5 to >4.45 pts
Excellent
Uses correct grammar, spelling, and punctuation with no errors
4.45 to >3.95 pts
Good
Contains a few (1–2) grammar, spelling, and punctuation errors
3.95 to >3.45 pts
Fair
Contains several (3–4) grammar, spelling, and punctuation errors
3.45 to >0 pts
Poor
Contains many (≥ 5) grammar, spelling, and punctuation errors that interfere with the reader’s understanding
5 pts
Total Points: 100
Previous Next